Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer (Q58614253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Begoña Navalpotro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Josep Tabernero Caturla

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

M Alsina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

C Aura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

K Caci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Jimenez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

L Prudkin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Castro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D Moreno

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Scaltriti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

17 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

438-439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

Comprehensive molecular characterization of gastric adenocarcinoma

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU535

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU535

Cyclin E and survival in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU535

Combined Evaluation of Expressions of Cyclin E and p53 Proteins as Prognostic Factors for Patients with Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU535

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU535

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDU535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403579%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference